This review has provided a multitude of examples wherein tumor-intrinsic alterations to energy, amino acid, and lipid metabolism have a significant impact on CD8+ T cell function and resistance to anti-PD-1/PD-L1 therapies [Table 1 and Figure 4]. The gene discussed is PDCD1; the disease is neoplasm.